Traws PharmaTRAW
13F holders, Q1 2025 (March 31)18holders
3new positions
3sold out
1famous investor
$2.30avg. 13F price*
At the end of Q1 2025, 18 institutions reported holding Traws Pharma Inc. (TRAW) in their 13F filings, unchanged from Q4 2024. 3 opened new positions and 3 sold out. The largest holders were Orbimed Advisors LLC ($1.4M), Perceptive Advisors LLC ($970K) and Adage Capital Partners Gp, L.L.C. ($759K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Traws Pharma Inc.
- CUSIP
- 68232V884
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $767K |
| Exits | 3 | $100K |
All 13F filers, Q4 2024 → Q1 2025: 722,314 shares bought and 160,411 shares sold, net +561,903 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Orbimed Advisors LLC | 0.03% | No change | 605,531 | $1.4M |
| Perceptive Advisors LLC | 0.03% | Add +156.9% | 421,781 | $970K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | New | 330,000 | $759K |
| Vestal Point Capital, LP | 0.03% | Add +133.3% | 175,000 | $403K |
| Alyeska Investment Group, L.P. | 0.00% | Reduce -54.9% | 52,630 | $121K |
| Geode Capital Management, LLC | 0.00% | Add +60.5% | 33,379 | $77K |
| Boothbay Fund Management, LLC | 0.00% | Add +17.1% | 33,305 | $77K |
| Ikarian Capital, LLC | 0.02% | Reduce -71.1% | 28,493 | $66K |
| UBS Group AG | 0.00% | Add +1710.8% | 14,323 | $33K |
| Vanguard Group Inc. | 0.00% | Add +0.2% | 13,173 | $30K |
| Millennium Management | 0.00% | Add +0.6% | 10,071 | $23K |
| BlackRock, Inc. | 0.00% | No change | 9,956 | $23K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 3,261 | $8K |
| Morgan Stanley | 0.00% | Reduce -95.4% | 725 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +227.1% | 507 | $1K |
| Vermillion & White Wealth Management Group, LLC | 0.00% | Reduce -53.2% | 96 | $221 |
| Bank of America Corp. | 0.00% | No change | 76 | $175 |
| FMR LLC | 0.00% | New | 2 | $5 |
"% of holder's portfolio" is TRAW's weight in each manager's 13F, not the share of Traws Pharma Inc. the manager owns.